Pricing Log in Create free account

Adagene Inc. Sponsored ADR (ADAG) vs AN2 Therapeutics, Inc. (ANTX)

Adagene Inc. Sponsored ADR and AN2 Therapeutics, Inc. are both Biotechnology companies. Adagene Inc. Sponsored ADR and AN2 Therapeutics, Inc. are of similar size ($161.8M and $160.4M). Across the 7 metrics below, Adagene Inc. Sponsored ADR leads on 4 and AN2 Therapeutics, Inc. on 3.

Valuation

Metric ADAG ANTX Biotechnology median
P/E — n/m 10.26
P/S — n/m 9.18
P/B n/m 2.34 2.05
Price to free cash flow n/m n/m 24.81
EV/EBITDA n/m n/m 0.65
EV/Sales n/m n/m 8.98
Earnings yield — (26.95%) (34.89%)
Free cash flow yield 0.00% (17.27%) (24.52%)

Profitability

Metric ADAG ANTX Biotechnology median
Gross margin — 0.00% 65.16%
Operating margin — 0.00% 0.00%
Net margin — 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity 0.00% (50.12%) (50.12%)
Return on assets 0.00% (46.06%) (45.60%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric ADAG ANTX Biotechnology median
Revenue growth (TTM) — — 6.26%
EPS growth (last fiscal year) 49.15% 32.56% 29.88%
Revenue growth, 5-year CAGR 61.38% — 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ADAG ANTX Biotechnology median
Debt to equity 0.01 0.00 0.00
Current ratio 5.02 14.32 4.89
Net debt to EBITDA 3.46 1.48 1.01

Dividend

Metric ADAG ANTX Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric ADAG ANTX Biotechnology median
Market cap 161.81m 160.38m 172.11m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack